HenryRichardAlexanderJr.MD

PubMed

• 401 citations
  Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.
  Steven K. Libutti, Giulio F. Paciotti, Adriana A. Byrnes, H. Richard Alexander, William E. Gannon
  Clinical Cancer Research. 2010-12-15
• 127 citations
  Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
  Markus Puhlmann, C K Brown, Michael Gnant, James Huang, Steven K. Libutti
  Cancer Gene Therapy. 2000-01-01
• 36 citations
  Sensitization of Tumor Necrosis Factor α-resistant Human Melanoma by Tumor-specific in Vivo Transfer of the Gene Encoding Endothelial Monocyte-activating Polypeptide I...
  Michael Gnant, Adam C. Berger, James Huang, Markus Puhlmann, Peter Wu
  Cancer Research. 1999-09-15

Journal Articles

• Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer  
  Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP, Clin Cancer Res, 9/15/2013
• FOXL1, a Novel Candidate Tumor Suppressor, Inhibits Tumor Aggressiveness and Predicts Outcome in Human Pancreatic Cancer  
  Zhang G, He P, Gaedcke J, Ghadmi BM, Ried T, Yfantis HG, Lee DH, Hanna N, Alexander HR, Hussain SP, Cancer Res, 9/1/2013
• Diffuse Mesothelioma of the Peritoneum: A Pathological Study of 64 Tumors Treated with Cytoreductive Therapy  
  Lee M, Alexander HR, Burke A, Pathology, 8/1/2013
• Assessment of Neoadjuvant Chemotherapy on Operative Parameters and Outcome in Patients with Peritoneal Dissemination from High-grade Appendiceal Cancer  
  Turner KM, Hanna NN, Zhu Y, Jain A, Kesmodel SB, Switzer RA, Taylor LM, Richard Alexander H Jr, Ann Surg Oncol, 4/1/2013
• von Hippel-Lindau Disease-associated Solid Microcystic Serous Adenomas Masquerading as Pancreatic Neuroendocrine Neoplasms  
  Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Gesuwan K, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ, Surgery, 12/1/2012
• Macrophage Migration Inhibitory Factor Induces Epithelial to Mesenchymal Transition, Enhances Tumor Aggressiveness and Predicts Clinical Outcome in Resected Pancreatic...  
  Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T, Yfantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back TC, Yanaga K, Hanna N, Alexa..., Int J Cancer, 7/23/2012
• Macrophage Migration Inhibitory Factor (MIF) Induces Epithelial to Mesenchymal Transition, Enhances Tumor Aggressiveness and Predicts Clinical Outcome in Resected Panc...  
  Funamizi N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi BM, Ried T, Yffantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back T, Yanaga K, Hanna N, Alexa..., Int J Cancer, 6/1/2012
• 18F-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal Mesothelioma  
  Cao Q, Lu M, Heath J, Hausner P, Alexander HR, Dilsizien V, Chen W, Clin Nuc Med, 5/1/2012
• Concepts of Regional Therapies for Advanced Malignancies  
  Gamblin TC, Alexander HR, Edwards R, Bartlett DL, Ann Surg Oncol, 2/3/2012
• Ethical Considerations in Clinical Research  
  Bellavance EC, Alexander HR, Ann Surg Oncol, 2/1/2012
• Current Concepts in the Evaluation and Treatment of Patients with Diffuse Malignant Peritoneal Mesothelioma  
  Turner KM, Varghese S, Alexander HR, J Natl Compr Canc Netw, 1/1/2012
• DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma  
  Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP, PLoS One, 1/1/2012
• Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis Dissemination from Colorectal Cancer  
  Turner K, Alexander HR, Colorect Cancer, 1/1/2012
• Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal God-rhTNF Nanonmedicine  
  Libutti SK, Paciotti GF, Byrnes AA, Alexander HR, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L, Clin Cancer Res, 12/1/2011
• Activation of P13K and mTOR Signaling Pathways Is Associated with Shortened Survival in Patients with Malignant Peritoneal Mesothelioma  
  Varghese S, Chen Z, Bartlett DL, Pingpank JF, Libutti SK, Steinberg SM, Wunderlich J, Alexander HR, Cancer, 1/1/2011
• Endocrine Cancers  
  Alexander HR, Pacak K, Seminars in Oncology, 12/1/2010
• Consequences of Adrenal Venous Sampling in Primary Hyperaldosteronism and Predictors of Unilateral Adrenal Disease  
  Mathur A, Kemp CD, Dutta U, Baid S, Ayala A, Chang RE, Steinberg SM, Papademetriou V, Lange E, Libutti SK, Pingpank JF, Alexander HR, Phan GQ, Hughes M, Linehan WM, Pi..., J Am Coll Surg, 9/1/2010
• Isolated Hepatic Perfusion with High-dose Melphalan Results in Immediate Alterations in Tumor Gene Expression in Patients with Metastatic Ocular Melanoma  
  Varghese S, Xu H, Bartlett DL, Hughes M, Pingpank JF, Beresnev T, Alexander HR, Ann Surg Oncol., 3/11/2010
• Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients with Isolated and Unresectable Liver Metastases  
  Alexander HR, Butler CC, Cancer J, 3/1/2010
• A Pilot Feasibility Study of TNFeradeTM Biological with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer  
  Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, Shuttack Y, Libutti SK, Oncology, 1/1/2010
• Reoperation for Parathyroid Adenoma: A Contemporary Experience  
  Powell AC, Alexander HR, Chang R, Marx SJ, Skarulis M, Pingpank JF, Bartlett DL, Hughes M, Weinstein LS, Simonds WF, Collins MF, Shawker T, Chen CC, Reynolds J, Cochra..., Surgery, 12/1/2009
• Analysis of Factors Influencing Outcome in Patients with In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters  
  Alexander HR Jr., Fraker DL, Bartlett DL, Libutti SK, Steinberg SM, Soriano P, Beresnev T, J Clin Oncol., 11/9/2009
• Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present, and Future  
  Alexander HR Jr., Ann Surg Oncol, 11/4/2009
• Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Cancer  
  Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB RN., Beresneva TH, Ann Surg Oncol, 7/1/2009
• Localization of Insulinomas to Regions of the Pancreas by IntraArterial Calcium Stimulation: The NIH Experience  
  Guettier J-M, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR, Libutti SK, Pingpank JF, Gorden P, JCEM, 4/1/2009
• Join now to see all

Books/Book Chapters

• Surgery for Peritoneal Mesothelioma 
  Turner KM, Varghese S, Alexander HR2011
• Methods in Bioengineering Series Organ Preservation and Reengineering 
  Chapter: Technique of Clinical Vascular Isolation and Perfusion of the Liver 
  Ambi CM, Alexander HREditors: Uygun K, Yee CY.2011
• Cutaneous Melanoma 
  Chapter: Isolation Perfusion for Extremity Melanoma 
  Alexander HR, Fraker DL, Eggermont AMMEditors: Balch, Houghton, Sober, Soong.Atkins, & ThompsonEdition 5th,2008
• Cancer: Principles and Practice of Oncology 
  Chapter: Isolated Perfusion and Isolated Infusion 
  Alexander HREditors: DeVita, VT, Rosenberg, SA.LawrenceEdition 8th,2007
• Principles and Practice of Oncology 
  Chapter: Metastatic Cancer to the Liver 
  Alexander HREditors: DeVita, VT, Rosenberg, SA.LawrenceEdition 8th,2007
• Cancer; Principles and Practice of Oncology 
  Chapter: Treatment of Unresectable Cancers Confined to Liver Using Vascular Isolation and Perfusion 
  Alexander, HR., Weinreich D2001
• Cancer: Principles & Practice of Oncology 
  Chapter: Isolation Perfusion 
  Page 769 - 787Alexander, HR.Editors: DeVita, V.T., Hellman, S., Rosenberg, S.A..Lippincott Williams & Wilkins, Philadelphia, PA2001
• Cancer: Principles & Practice of Oncology 
  Chapter: Metastatic Cancer to the Liver 
  Page 2690 - 2713Alexander, HR., Allegra, C.J., Lawrence, T.S.Editors: DeVita, V.T., Hellman, S., Rosenberg, S.A..Lippincott Williams & Wilkins, Philadelphia, PA2001
• Cancer: Principles & Practice of Oncology 
  Chapter: Pancreatic Endocrine Tumors 
  Page 1788 - 1813Alexander, HR., Jensen, R.T.Editors: DeVita, V.T., Hellman, S., Rosenberg, S.A..Lippincott Williams & Wilkins, Philadelphia, PA2001
• Hepatobiliary Cancer 
  Chapter: Isolated Hepatic Perfusion 
  Bartlett, D., Alexander, HR.Editors: Steele, G., Phillips, T., Chabner, B..B.C.Decker, Inc., Hamilton, London2001
• Surgical Endocrinology 
  Chapter: Management of Hyperparathyroidism in Multiple Endocrine Neoplasia Type I 
  Berger, A., Alexander, HR.Editors: Doherty, G., Skogseid, B..Lippincott Williams & Wilkins, Philadelphia, PA2001
• Biologic Therapy of Cancer 
  Chapter: Tumor Necrosis Factor: Basic Principles and Clinical Application in Systemic and Regional Cancer Treatment 
  Page 174 - 193Feldman, A.F., Alexander, HR.Editors: DeVita, V.T., Hellman, S., Rosenberg, S.A..J.B. Lippincott, Williams & Wilkins Co., Philadelphia, PA2000
• Integrated Cancer Management: Surgery, Medical Oncology and Radiation Oncology 
  Chapter: Pancreatic Endocrine Tumors 
  Page 241 - 268Alexander, HR., Jr., Jensen, R.T., Doppman, J.L.Editors: Torosian, M.Marcel Dekker, NY1999
• Topics in Palliative Care 
  Chapter: Prevalence and Pathophysiology of Cancer Cachexia 
  Page 91 - 129Ma, Grace, Alexander, HREditors: Bruera, E, Portenoy, R.K..1998
• Regional Therapy of Advanced Cancer 
  Chapter: Isolated Perfusion of the Liver 
  Page 141 - 150Fraker, D.L., Alexander, HREditors: Lotze, M.T., Rubin, J.T..Raven-Lippincott1997
• Cancer Principles and Practice of Oncology 
  Chapter: Cancer of the Stomach 
  Page 1021 - 1053Alexander, HR, Kelsen, D.P., Tepper, J.E.Editors: DeVita, V.T., Jr., Hellman, S., Rosenberg, S.A..J.B. Lippincott, PhiladelphiaEdition 5th,1997
• Cancer Principles and Practice of Oncology 
  Chapter: Vascular Access and Specialized Techniques of Drug Delivery 
  Page 725 - 734Alexander, HREditors: DeVita, V.T., Jr., Hellman, S., Rosenberg, S.A..J.B. Lippincott, PhiladelphiaEdition 5th,1997
• Oxford Textbook of Palliative Medicine 
  Chapter: The Pathophysiology of Cachexia in Advanced Cancer and AIDS 
  Page 1 - 22Billingsley, K.G., Alexander, HR.Editors: Bruera, E., Higginson, I..Oxford University Press, Oxford, England1996
• Cancer. Principles and Practice of Oncology 
  Chapter: Regional Treatment Strategies for Unresectable Primary or Metastatic Cancer Confined to the Liver 
  Page 1 - 19Alexander, HR, Bartlett, D.L., Fraker, D.L., Libutti, S.K.Editors: DeVita, V.T., Jr., Hellman, S., Rosenberg, S.A..J.B. Lippincott, PhiladelphiaEdition 4th,1996
• Principles and Practices of Oncology Updates 
  Chapter: Rationale and Clinical Status of Continuous Hyperthermic Peritoneal Perfusion (CHPP) For the Treatment of Peritoneal Carcinomatosis 
  Page 1 - 9Alexander, HR, Buell, J.F., Fraker, D.L.Editors: DeVita, V., Hellman, S., Rosenberg, S..J.B. Lippincott, Philadelphia1996
• Bone Marrow Transplantation 
  Chapter: Diagnosis and Management of Complications Related to Long-term Venous Access Devices 
  Page 333 - 342Alexander, HREditors: Burt, R.K., Deeg, H.J., Lothian, S.T., Santos, G.W..R.G. Landes, Austin, Texas1996
• Protein and Amino Acid Metabolism in Cancer Cachexia 
  Chapter: Cytokines in Cancer Cachexia 
  Page 51 - 72Billingsley, K.G., Alexander, HR.Editors: Pisters, P., Brennan, M.F..R.G. Landes, Austin, Texas1996
• Peritoneal Carcinomatosis: Drugs and Diseases 
  Chapter: Treatment of Peritoneal Carcinomatosis by Continuous Hyperthermic Peritoneal Perfusion with Cisplatin 
  Page 41 - 50Alexander, HR., Fraker, D.L.Editors: Sugarbaker, P.Academic Publishers, Norwell, MA1996
• Conn's Current Therapy 
  Chapter: Tumors of the Stomach 
  Alexander, H.R.Editors: Rakel, R.E.W.B. Saunders, Philadelphia1996
• Williams Hematology 
  Chapter: The Use of Venous Access Devices 
  Page 200 - 202Steinhaus, Elizabeth and Alexander HREditors: Beutler, E., Lichtman, M.A., Coller, B.S., Kipps, T.J..McGraw Hill, Inc., New YorkEdition 5th,1995
• Join now to see all

Abstracts/Posters

• Percutaneous Hepatic Perfusion (PHP or ChemoSAT) With Melphalan versus Best Alternative Care (BAC) In Patients (Patients with Hepatic Metastases from Melanoma: A Post ...
  Alexander HR, et al., American Society of Clinical Oncology Annual Meeting, 6/1/2012
• von Hipple-Lindau Disease-associated Solid Microcystic Adenomas Masquerading as Pancreatic Neuroendocrine Tumors
  Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ, American Association of Endocrine Surgeons Annual Meeting, National Institutes of Health, National Cancer Institute, Albert Einstein College of Medicine, Unive, 4/1/2012
• Value of Surgery in Patients with Negative Imaging and Sporadic Zollinger-Ellison Syndrome
  Norton JA, Fraker DL, Alexander HR, Jensen RT, Stanford University, Stanford, CA, NIADDK, NIH Bethesda, MD, American Surgical Association 132nd Annual Meeting, San Francisco, CA, 4/1/2012
• Assessment of Neoadjuvant Chemotherapy on Operative Parameters and Outcome in Patients with Peritoneal Dissemination from High Grade Appendiceal Cancer
  Turner K, Hanna NN, Zhu Y, Jain A, Kesmodel SB, Switzer RA, Taylor LM, Alexander HR; Division of Surgical Oncology, Department of Surgery, and the Marlene and Stewart ..., Society of Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 3/1/2012
• Percutaneous Hepatic Perfusion (PHP) Vs. Best Alternative Care (BAC) for Patients (pts) with Melanoma Liver Metastases - Efficacy Update of the Phase 3 Trial (NCT00324...
  Alexander HR, "Melanoma and Skin Cancer". 2011 European Multidisciplinary Cancer Congress, Stockholm, Sweden, 9/1/2011
• A Phase III Random Assignment Trial Comparing Percutaneous Hepatic Perfusion with Melphalan (PHPmel) To Standard of Care for Patients with Hepatic Metastases from Meta...
  Pingpank JF, Hughes MS, Alexander HR, Faries MB, Zager JS, Royal R, Whitman ED, Nutting CW, Siskin GP, Agarwala SS; University of Pittsburgh, Hillman Cancer Center, Pi..., American Society of Clinical Oncology 2010 Annual Meeting, Chicago, IL, 6/1/2010
• Adrenal Venous Sampling in Primary Hyperaldosteronism Standardizing a Gold Standard
  Mathur A, Kemp CD, Dutta U, Baid S, Ayala A, Chang RE, Steinberg S, Lange E, Pingpank JF, Alexander HR, Linehan WM, Pinto PA, Phan G, Hughes MB , Libutti SK, Stratakis..., The American Association of Endocrine Surgeons 31 st Annual Meeting, Pittsburgh, PA, 4/1/2010
• A Phase III Random Assignment Trial Comparing Percutaneous Hepatic Perfusion with Melphalan (PHPmel) To Standard of Care for Patients with Hepatic Metastases from Meta...
  Pingpank JF, Hughes MS, Alexander HR, Faries MB, Zager JS, Royal R, Whitman ED, Nutting CW, Siskin GP, Agarwala SS; University of Pittsburgh, Hillman Cancer Center, Pi..., Society of Surgical Oncology 60th Annual Cancer Symposium. Annals of Surgical Oncology Abstract Book, 2/1/2010
• Reoperation for Parathyroid Adenoma: A Contemporary Experience
  Powell AC, Alexander HR, Chang R, Marx SJ, Skarulis M, Pingpank JF, Bartlett DL, Hughes MB, Weinstein LS, Simonds WF, Collins MF, Shawker T, Chen CC, Reynolds J, Cochr..., American Association of Endocrine Surgeons Meeting, Madison, WI, 5/1/2009
• Interleukin-1 and It Signalling Pathway Are Overexpressed and Regulate Interleukin-8 in Malignant Peritoneal Mesothelioma
  Varghese S, Pingpank JF, Xu H, Choudhry S, Alexander HR, AACR Annual Meeting, San Diego, CA, 4/1/2008
• The Utility of Routine Transcervical Thymectomy (TCT) for MEN1 Related Hyperparathyroidism
  Powell AC, Alexander HR, Pingpank JF, Skarulis M, Bartlett DL, Cochran C, Seidel G, Fraker D, Jensen R, Marx S, Libutti SK, American Association of Endocrine Surgeons Meeting, Monterey, CA, 4/1/2008
• Technical Considerations in Hepatic Arterial Infusion of High Dose Melphalan with Hepatic Venous Hemofiltration
  Kam AW, Wood BJ, Chang R, Neeman Z, Chen EA, Royal R, Kammula U, Libutti SK, Hughes M, Alexander HR, Pinkpank, JF, Society of Interventional Radiology 33rd Annual Scientific Meeting, Washington, DC, 3/1/2008
• Pro-Inflammatory and Angiogenic Serum and Tumor Profiles in Patients with Malignant Peritoneal Mesothelioma (MPM)
  Gallagher K, Varghese S, Pingpank JF, Libutti SK, Alexander HR, Society of Surgical Oncology 60th Annual Cancer Symposium. Annals of Surgical Oncology, 2/1/2007
• Targeting the Tumor Microenvironment to Treat Human Ocular Melanoma in Nude Mice Using the Tyrosine Kinase Inhibitors (TKIs) Sunitinib or Sorafenib Alone and in Combin...
  Blansfield JA, Alexander HR, Morita S, et al., Society of Surgical Oncology 60th Annual Cancer Symposium. Annals of Surgical Oncology, 2/1/2007
• Prolonged Survival in 101 Patients with Malignant Peritoneal Mesothelioma Undergoing Systemic Surgical Cytoreduction, Continuous Hyperthermic Peritoneal Perfusion (CHP...
  Greer SE, Alexander HR, Libutti SK, et al., Society of Surgical Oncology 60th Annual Cancer Symposium. Annals of Surgical Oncology, 2/1/2007
• Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion (IHP) for Unresectable Liver Metastases from Colorectal Cancer
  Alexander HR, Pingpank JF, Libutti SK, et al., Society of Surgical Oncology 60th Annual Cancer Symposium. Annals of Surgical Oncology, 2/1/2007
• Cytoreductive Surgery with Continuous Hyperthermic Peritoneal Perfusion with Cisplatin (CHPP) Analysis of Morbidity and Mortality in 266 Patients Treated at a Single I...
  Blansfield J, Libutti S, Royal R, Alexander HR, Hughes MB, Steinberg S, Ohl S, Beresneva T, Pingpank J, SSAT Oral Presentation, 1/1/2007
• Molecular Pathology of the MEN1 Gene
  Agarwal SK, Burns AL, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB, Mullendore ME, Whitten I, Skarulis MC, Simonds WF, Mateo C, Crabtree JS, Scacheri PC, Ji Y, No..., Annals of the New York Academy of Sciences, 2nd International Conference on Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Diseases, Berlin, 6/19/2003
• Current Status of Isolated Hepatic Perfusion with or without Tumor Necrosis Factor for the Treatment of Unresectable Cancers Confined to Liver
  Alexander, R., Bartlett, D., Libutti, S, The Oncologist, NCI All Ireland Cancer Conference, 1/1/2000
• Join now to see all

Lectures

• Historical Perspectives on CRS and HIPEC 
  Jalisciense Cancer Institute, Guadalajara, Mexico - 1/1/2014
• CRS and HIPEC for Ovarian Cancer 
  Jalisciense Cancer Institute, Guadalajara, Mexico - 1/1/2014
• Centers of Excellence for Peritoneal Surface Malignancies 
  Phoenix, AZ - 1/1/2014
• Development of Percutaneous Hepatic Perfusion as Treatment for Patients with Unresectable Liver Metastases 
  Alicante, Spain - 1/1/2013
• Management of Pseudomyxoma Peritonei 
  Alicante, Spain - 1/1/2013
• Translational Research Advances in Malignant Mesothelioma 
  Baltimore, MD - 1/1/2013
• Management of Cystic Neoplasms of the Pancreas 
  University of Maryland School of Medicine - 1/1/2013
• Advances in the Treatment of Malignant Peritoneal Mesothelioma 
  Cancun, Mexico - 1/1/2013
• Hepatic Perfusion for the Treatment of Metastatic Cancer 
  Cancun, Mexico - 1/1/2013
• Use of Regional Perfusion for the Treatment of Liver Metastases 
  Oaxaca Regional Specialty Hospital - 1/1/2013
• Treatment of Malignant Peritoneal Mesothelioma: State of the Science 
  Oaxaca Regional Specialty Hospital - 1/1/2013
• Cytoreduction and HIPEC for Patients with Peritoneal Metastases from CRC 
  University of Delaware Christiana Hospital, Newark, DE - 1/1/2012
• Gene Expression Profiling Predicts Outcome in Patients with MPM 
  University of Pittsburgh Captiva, FL - 1/1/2012
• State of the Art in the Management of Peritoneal Pseudomyxoma 
  Ixtapa, Guerrero, Mexico - 1/1/2011
• Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) in Colorectal Cancer 
  Arlington, VA - 1/1/2011
• Hepatic Isolation and Perfusion for Diffuse Liver Metastases 
  Baltimore, MD - 1/1/2011
• Experimental Strategies in Peritoneal Mesothelioma 
  Washington, DC - 1/1/2011
• Surgical Management of Peritoneal Dissemination from Lower GI Cancers: Evidence-based Decision Making for Cytoreduction and Intraperitoneal Hyperthermic Perfusion 
  University of Massachusetts Memorial Medical Center, Worcester, MA - 1/1/2011
• History of IHP and PHP and What's Needed to Set Up the Program 
  San Antonio, Texas - 1/1/2011
• Evidence for the Use of Cytoreduction & HIPEC: A Strategy to Control Peritoneal Carcinomatosis from Gastrointestinal Cancer 
  University of Maryland Medical Center - 1/1/2011
• Lessons Learned from the Use of TNF in Regional Perfusion 
  1/1/2010
• The History of Cancer Treatment in the United States: Perspectives from a Cancer Surgeon 
  Holy Cross Hospital, Rockville, MD - 1/1/2010
• Modern Advances for Treatment of Primary Peritoneal Malignancies 
  University of Maryland School of Medicine, Baltimore, MD - 1/1/2010
• Isolation Perfusion for Treatment of Patients with Metastatic Melanoma 
  Shady Grove Aventis Hospital, Rockville, MD - 1/1/2010
• Cytoreduction and HIPEC in the Management of Patients with Foregut Cancers 
  Uppsala, Sweden - 1/1/2010
• Join now to see all

Other

• Malignant Peritoneal Mesothelioma 
  Alexander HR, UpToDate
  1/1/2013
• Miles for Meso Race 
  
  Palm Beach, Florida - 1/1/2011